AllianceBernstein’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.96M | Buy |
170,949
+77,929
| +84% | +$3.48M | ﹤0.01% | 1311 |
|
|
2025
Q4 | $4.33M | Hold |
93,020
| – | – | ﹤0.01% | 1611 |
|
|
2025
Q3 | $3.87M | Hold |
93,020
| – | – | ﹤0.01% | 1643 |
|
|
2025
Q2 | $2.68M | Sell |
93,020
-17,654
| -16% | -$545K | ﹤0.01% | 1787 |
|
|
2025
Q1 | $3.71M | Buy |
110,674
+8,954
| +9% | +$334K | ﹤0.01% | 1576 |
|
|
2024
Q4 | $5.2M | Buy |
101,720
+9,190
| +10% | +$514K | ﹤0.01% | 1471 |
|
|
2024
Q3 | $4.73M | Hold |
92,530
| – | – | ﹤0.01% | 1538 |
|
|
2024
Q2 | $4.14M | Buy |
92,530
+25,260
| +38% | +$1.17M | ﹤0.01% | 1565 |
|
|
2024
Q1 | $3.15M | Hold |
67,270
| – | – | ﹤0.01% | 1669 |
|
|
2023
Q4 | $2.39M | Buy |
67,270
+6,130
| +10% | +$188K | ﹤0.01% | 1840 |
|
|
2023
Q3 | $1.82M | Buy |
61,140
+9,940
| +19% | +$205K | ﹤0.01% | 1927 |
|
|
2023
Q2 | $923K | Hold |
51,200
| – | – | ﹤0.01% | 2322 |
|
|
2023
Q1 | $822K | Hold |
51,200
| – | – | ﹤0.01% | 2321 |
|
|
2022
Q4 | $937K | Hold |
51,200
| – | – | ﹤0.01% | 2319 |
|
|
2022
Q3 | $1.01M | Hold |
51,200
| – | – | ﹤0.01% | 2286 |
|
|
2022
Q2 | $955K | Buy |
51,200
+21,600
| +73% | +$431K | ﹤0.01% | 2371 |
|
|
2022
Q1 | $650K | Buy |
29,600
+100
| +0.3% | +$2.02K | ﹤0.01% | 2567 |
|
|
2021
Q4 | $838K | Hold |
29,500
| – | – | ﹤0.01% | 2535 |
|
|
2021
Q3 | $621K | Hold |
29,500
| – | – | ﹤0.01% | 2673 |
|
|
2021
Q2 | $556K | Buy |
29,500
+2,700
| +10% | +$47.4K | ﹤0.01% | 2773 |
|
|
2021
Q1 | $410K | Sell |
26,800
-1,100
| -4% | -$17K | ﹤0.01% | 2758 |
|
|
2020
Q4 | $394K | Buy |
27,900
+2,000
| +8% | +$27.9K | ﹤0.01% | 2706 |
|
|
2020
Q3 | $406K | Hold |
25,900
| – | – | ﹤0.01% | 2642 |
|
|
2020
Q2 | $454K | Buy |
25,900
+11,100
| +75% | +$189K | ﹤0.01% | 2676 |
|
|
2020
Q1 | $218K | Buy |
14,800
+3,000
| +25% | +$61.5K | ﹤0.01% | 2760 |
|
|
2019
Q4 | $296K | Buy |
11,800
+600
| +5% | +$11.4K | ﹤0.01% | 2780 |
|
|
2019
Q3 | $168K | Buy |
11,200
+2,200
| +24% | +$42.8K | ﹤0.01% | 2980 |
|
|
2019
Q2 | $225K | Buy |
+9,000
| New | +$223K | ﹤0.01% | 2925 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC